2025
How well do disease-specific studies and WHO-CHOICE cost estimates align? Example of estimating cost per episode of diarrhoea and respiratory syncytial virus in 128 low-income and middle-income countries
Li X, Bilcke J, Asare E, Wenger C, Kwon J, Bont L, Beutels P, Pitzer V. How well do disease-specific studies and WHO-CHOICE cost estimates align? Example of estimating cost per episode of diarrhoea and respiratory syncytial virus in 128 low-income and middle-income countries. BMJ Global Health 2025, 10: e016784. PMID: 40850784, PMCID: PMC12382583, DOI: 10.1136/bmjgh-2024-016784.Peer-Reviewed Original ResearchMeSH KeywordsCost-Benefit AnalysisDeveloping CountriesDiarrheaHealth Care CostsHumansRespiratory Syncytial Virus InfectionsRotavirus InfectionsWorld Health OrganizationConceptsRespiratory syncytial virusRSV-related diseaseWHO-CHOICE estimatesEpisodes of diarrheaLower middle-incomeWHO-CHOICELow-incomeUpper middle-incomeSyncytial virusRSV studiesInpatient costsMiddle-incomeDiarrhoeal diseaseEconomic evaluationCost studiesMiddle-income countriesDisease-specific diagnosisRSV-specificDisease-specific costsCost-effectiveness studiesDisease-specific studiesOutpatient costsEmpirical studiesDiarrheaCountry-specific data
2020
Meeting Report: WHO Workshop on modelling global mortality and aetiology estimates of enteric pathogens in children under five. Cape Town, 28–29th November 2018
Prudden H, Hasso-Agopsowicz M, Black R, Troeger C, Reiner R, Breiman R, Jit M, Kang G, Lamberti L, Lanata C, Lopman B, Ndifon W, Pitzer V, Platts-Mills J, Riddle M, Smith P, Hutubessy R, Giersing B. Meeting Report: WHO Workshop on modelling global mortality and aetiology estimates of enteric pathogens in children under five. Cape Town, 28–29th November 2018. Vaccine 2020, 38: 4792-4800. PMID: 32253097, PMCID: PMC7306158, DOI: 10.1016/j.vaccine.2020.01.054.Peer-Reviewed Original ResearchConceptsNumber of deathsWorld Health OrganizationEnteric diseaseEnteric pathogensVaccine Advisory CommitteeDifferent enteric pathogensDisease burden estimatesJohns Hopkins Bloomberg SchoolVaccine introduction decisionsVaccine product developmentMiddle-income countriesMortality estimatesVaccine prioritizationBurden estimatesGlobal burdenGlobal mortalityDisease estimatesBloomberg SchoolWorking GroupMajor causeHealth OrganizationHealth metricsIndependent working groupEstimation groupDeath
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply